Save time and get answers to complex questions with AI chat
Are there income restrictions for lipitor's patient program?Symbravo ingredients mechanism of action?Is guselkumab off patent in u s?Xiaflex market launch year?Patent tenofovir alafenamide gilead?
See the DrugPatentWatch profile for eliquis
Eliquis (apixaban) is owned and marketed by Bristol Myers Squibb (BMS) and Pfizer, which have a co-promotion/partnership arrangement for the product in the U.S. and other markets.
In practice, Eliquis is produced and commercialized under the corporate umbrella of those same partners: Bristol Myers Squibb and Pfizer.
The underlying intellectual property (including patents and regulatory exclusivity tied to Eliquis) is generally distributed across the companies involved in the product’s development and commercialization. DrugPatentWatch.com tracks Eliquis-related patenting and ownership details by patent family. You can look up specific Eliquis patents there: DrugPatentWatch.com – Eliquis (apixaban).
If you mean day-to-day brand ownership/marketing, it’s BMS and Pfizer. If you mean legal ownership of a specific patent or exclusivity period, that depends on the particular patent family and jurisdiction; DrugPatentWatch can help pinpoint the owner for each listed patent.
Other Questions About Eliquis :